Characterization of regulators of G-protein signaling RGS4 and RGS10 proteins in the postmortem human brain

Neurochemistry International

Volumn 57, Issue 7, 2010, Pages 722-729

  Rivero, Guadalupe ^a,b,g   Gabilondo, Ane M ^a,b   García Sevilla, Jesús A ^c,d   La Harpe, Romano ^e   Morentín, Benito ^f   Javier Meana, J ^a,b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^d Red Temática de Investigación Cooperativa en Salud RETICS Trastornos Adictivos   (Spain)

^e UNIVERSITY CENTER OF LEGAL MEDICINE   (Switzerland)

^f Basque Institute of Legal Medicine   (Spain)

^g UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Aging; Human brain; Postmortem changes; Regulators of G protein signaling; RGS10; RGS4; Western blot

Indexed keywords

RGS PROTEIN; RGS10 PROTEIN; RGS4 PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE; AGED; ANTIBODY SPECIFICITY; ARTICLE; AUTOPSY; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOL; FEMALE; GENDER; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MALE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SHELF LIFE; SIGNAL TRANSDUCTION; TIME OF DEATH;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GTP-BINDING PROTEINS; HUMANS; MALE; MIDDLE AGED; POSTMORTEM CHANGES; PREFRONTAL CORTEX; RGS PROTEINS; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 77958088159     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.08.008     Document Type: Article

References (70)

1. Abramow-Newerly M., Roy A.-A., Nunn C., Chidiac P. RGS proteins have a signaling complex, interactions between RGS proteins and GPCRs, effectors, and auxiliary proteins. Cell. Signal. 2006, 18:579-591.
2. Anger T., Zhang W., Mende U. Differential contribution of GTPase activation and effector antagonism to the inhibitory effect of RGS proteins on Gq-mediated signaling in vivo. J. Biol. Chem. 2004, 279:3906-3915.
3. Berman D.-M., Wilkie T.-M., Gilman A.-G. GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits. Cell 1996, 86:445-452.
4. Bernstein L.-S., Grillo A.-A., Loranger S.-S., Linder M.-E. RGS4 binds to membranes through an amphipathic alpha-helix. J. Biol. Chem. 2000, 275:18520-18526.
5. Bishop G.-B., Cullinan W.-E., Curran E., Gutstein H.-B. Abused drugs modulate RGS4 mRNA levels in rat brain, comparison between acute drug treatment and a drug challenge after chronic treatment. Neurobiol. Dis. 2002, 10:334-343.
6. Bodenstein J., Sunahara R.-K., Neubig R.-N. N-Terminal residues control proteasomal degradation of RGS2, RGS4, and RGS5 in human embryonic kidney 293 cells. Mol. Pharmacol. 2007, 71:1040-1050.
7. Bouhamdan M., Michelhaugh S.-K., Calin-Jageman I., Ahern-Djamali S., Bannon M.-J. Brain-specific RGS9-2 is localized to the nucleus via its unique proline-rich domain. Biochim. Biophys. Acta 2004, 1691:141-150.
8. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
9. Burgon P.-G., Lee W.-L., Nixon A.-B., Peralta E.-G., Casey P.-J. Phosphorylation and nuclear translocation of a regulator of G protein signaling (RGS10). J. Biol. Chem. 2001, 276:32828-32834.
10. Burke R.-E., Greenbaum D. Effect of postmortem factors on muscarinic receptor subtypes in rat brain. J. Neurochem. 1987, 49:592-596.
11. Cavalli A., Druey K.-M., Milligan G. The regulator of G protein signaling RGS4 selectively enhances alpha 2A-adrenoreceptor stimulation of the GTPase activity of Go1alpha and Gi2alpha. J. Biol. Chem. 2000, 275:23693-23699.
12. Chatterjee T.-K., Fisher R.-A. Cytoplasmic, nuclear, and golgi localization of RGS proteins. Evidence for N-terminal and RGS domain sequences as intracellular targeting motifs. J. Biol. Chem. 2000, 275:24013-24021.
13. Chatterjee T.-K., Fisher R.-A. RGS12TS-S localizes at nuclear matrix-associated subnuclear structures and represses transcription, structural requirements for subnuclear targeting and transcriptional repression. Mol. Cell. Biol. 2002, 22:4334-4345.
14. Cowburn R.-F., O'Neill C., Ravid R., Alafuzoff I., Winblad B., Fowler C.-J. Adenylyl cyclase activity in postmortem human brain, evidence of altered G protein mediation in Alzheimer's disease. J. Neurochem. 1992, 58:1409-1419.
15. Davydov I.-V, Varshavsky A. RGS4 is arginylated and degraded by the N-end rule pathway in vitro. J. Biol. Chem. 2000, 275:22931-22941.
16. Ding J., Guzman J.-N., Tkatch T., Chen S., Goldberg J.-A., Ebert P.-J., Levitt P., Wilson C.-J., Hamm H.-E., Surmeier D.-J. RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion. Nat. Neurosci. 2006, 9:832-842.
17. Ding L., Mychaleckyj J.C., Hegde A.-N. Full length cloning and expression analysis of splice variants of regulator of G-protein signaling RGS4 in human and murine brain. Gene 2007, 401:46-60.
18. Ding L., Hegde A.-N. Expression of RGS4 splice variants in dorsolateral prefrontal cortex of schizophrenic and bipolar disorder patients. Biol. Psychiatry 2009, 65:541-545.
19. Emilsson L., Saetre P., Jazin E. Low mRNA levels of RGS4 splice variants in Alzheimer's disease, association between a rare haplotype and decreased mRNA expression. Synapse 2006, 59:173-176.
20. Erdely H.-A., Lahti R.-A., Lopez M.-B., Myers C.-S., Roberts R.-C., Tamminga C.-A., Vogel M.-W. Regional expression of RGS4 mRNA in human brain. Eur. J. Neurosci. 2004, 19:3125-3128.
21. Garnier M., Zaratin P.-F., Ficalora G., Valente M., Fontanella L., Rhee M.-H., Blumer K.-J., Scheideler M.-A. Up-regulation of regulator of G protein signaling 4 expression in a model of neuropathic pain and insensitivity to morphine. J. Pharmacol. Exp. Therap. 2003, 304:1299-1306.
22. Garzón J., Rodríguez-Muñoz M., de la Torre-Madrid E., Sánchez-Blázquez P. Effector antagonism by the regulators of G protein signalling (RGS) proteins causes desensitization of mu-opioid receptors in the CNS. Psychopharmacology 2005, 180:1-11.
23. Georgoussi Z., Leontiadis L., Mazarakou G., Merkouris M., Hyde K., Hamm H. Selective interactions between G protein subunits and RGS4 with the C-terminal domains of the mu- and delta-opioid receptors regulate opioid receptor signaling. Cell. Signal. 2006, 18:771-782.
24. Geurts M., Maloteaux J.-M., Hermans E. Altered expression of regulators of G-protein signaling (RGS) mRNAs in the striatum of rats undergoing dopamine depletion. Biochem. Pharmacol. 2003, 66:1163-1170.
25. Ghavami A., Hunt R.-A., Olsen M.-A., Zhang J., Smith D.-L., Kalgaonkar S., Rahman Z., Young K.-H. Differential effects of regulator of G protein signaling (RGS) proteins on serotonin 5-HT1A, 5-HT2A, and dopamine D2 receptor-mediated signaling and adenylyl cyclase activity. Cell. Signal. 2004, 16:711-721.
26. Gold S.-J., Heifets B.-D., Pudiak C.-M., Potts B.-W., Nestler E.-J. Regulation of regulators of G protein signaling mRNA expression in rat brain by acute and chronic electroconvulsive seizures. J. Neurochem. 2002, 82:828-838.
27. Gold S.-J., Han M.-H., Herman A.-E., Ni Y.-G., Pudiak C.-M., Aghajanian G.-K., Liu R.-J., Potts B.-W., Mumby S.-M., Nestler E.-J. Regulation of RGS proteins by chronic morphine in rat locus coeruleus. Eur. J. Neurosci. 2003, 17:971-980.
28. González-Maeso J., Torre I., Rodríguez-Puertas R., García-Sevilla J.A., Guimón J., Meana J.-J. Effects of age, postmortem delay and storage time on receptor-mediated activation of G-proteins in human brain. Neuropsychopharmacology 2002, 26:468-478.
29. Gu Z., Jiang Q., Yan Z. RGS4 modulates serotonin signaling in prefrontal cortex and links to serotonin dysfunction in a rat model of schizophrenia. Mol. Pharmacol. 2007, 71:1030-1039.
30. Haller C., Fillatreau S., Hoffmann R., Agenes F. Structure, chromosomal localization and expression of the mouse regulator of G-protein signaling10 gene (mRGS10). Gene 2002, 297:39-49.
31. Hishimoto A., Shirakawa O., Nishiguchi N., Aoyama S., Ono H., Hashimoto T., Maeda K. Novel missense polymorphism in the regulator of G-protein signaling 10 gene, analysis of association with schizophrenia. Psychiatry Clin. Neurosci. 2004, 58:579-581.
32. Hoffmann M., Ward R.-J., Cavalli A., Carr I.-C., Milligan G. Differential capacities of the RGS1, RGS16 and RGS-GAIP regulators of G protein signaling to enhance alpha2A-adrenoreceptor agonist-stimulated GTPase activity of G(o1)alpha. J. Neurochem. 2001, 78:797-806.
33. Hollinger S., Hepler J.-R. Cellular regulation of RGS proteins, modulators and integrators of G protein signaling. Pharmacol. Rev. 2002, 54:527-559.
34. Huang C., Hepler J.-R., Gilman A.-G., Mumby S.-M. Attenuation of Gi- and Gq-mediated signaling by expression of RGS4 or GAIP in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:6159-6163.
35. Hunt T.-W., Fields T.-A., Casey P.-J., Peralta E.-G. RGS10 is a selective activator of G alpha i GTPase activity. Nature 1996, 383:175-177.
36. Ishii M., Kurachi Y. Physiological actions of regulators of G-protein signaling (RGS) proteins. Life Sci. 2003, 74:163-171.
37. Kim E., Arnould T., Sellin L., Benzing T., Comella N., Kocher O., Tsiokas L., Sukhatme V.-P., Walz G. Interaction between RGS7 and polycystin. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:6371-6376.
38. Krumins A.-M., Barker S.-A., Huang C., Sunahara R.-K., Yu K., Wilkie T.-M., Gold S.-J., Mumby S.-M. Differentially regulated expression of endogenous RGS4 and RGS7. J. Biol. Chem. 2004, 279:2593-2599.
39. Larminie C., Murdock P., Walhin J.-P., Duckworth M., Blumer K.-J., Scheideler M.-A., Garnier M. Selective expression of regulators of G-protein signaling (RGS) in the human central nervous system. Mol. Brain Res. 2004, 122:24-34.
40. Leone A.-M., Errico M., Lin S.-L., Cowen D.-S. Activation of extracellular signal-regulated kinase (ERK) and Akt by human serotonin 5-HT1B receptors in transfected BE(2)-C neuroblastoma cells is inhibited by RGS4. J. Neurochem. 2000, 75:934-938.
41. Leygraf A., Hohoff C., Freitag C., Willis-Owen S.-A., Krakowitzky P., Fritze J., Franke P., Bandelow B., Fimmers R., Flint J., Deckert J. Rgs2 gene polymorphisms as modulators of anxiety in humans?. J. Neural Transm. 2006, 113:1921-1925.
42. Lipska B.-K., Mitkus S., Caruso M., Hyde T.-M., Chen J., Vakkalanka R., Straub R.-E., Weinberger D.-R., Kleinman J.-E. RGS4 mRNA expression in postmortem human cortex is associated with COMT Val158Met genotype and COMT enzyme activity. Hum. Mol. Genet. 2006, 15:2804-2812.
43. Mirnics K., Middleton F.-A., Stanwood G.-D., Lewis D.-A., Levitt P. Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol. Psychiatry 2001, 6:293-301.
44. Morris D.-W., Rodgers A., McGhee K.-A., Schwaiger S., Scully P., Quinn J., Meagher D., Waddington J.-L., Gill M., Corvin A.-P. Confirming RGS4 as a susceptibility gene for schizophrenia. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2004, 125:50-53.
45. Muma N.-A., Mariyappa R., Williams K., Lee J.-M. Differences in regional and subcellular localization of Gq/11 and RGS4 protein levels in Alzheimer's disease, correlation with muscarinic M1 receptor binding parameters. Synapse 2003, 47:58-65.
46. Nishiguchi K.-M., Sandberg M.-A., Kooijman A.-C., Martemyanov K.-A., Pott J.-W., Hagstrom S.-A., Arshavsky V.-Y., Berson E.-L., Dryja T.-P. Defects in RGS9 or its anchor protein R9AP in patients with slow photoreceptor deactivation. Nature 2004, 427:75-78.
47. Ozawa H., Ukai W., Kornhuber J., Yamaguchi T., Froelich L., Ikeda H., Saito T., Riederer P. Postnatal ontogeny of GTP binding protein in the human frontal cortex. Life Sci. 1999, 65:2315-2323.
48. Paspalas C.-D., Selemon L.-D., Arnsten A.-F. Mapping the regulator of G protein signaling 4 (RGS4): presynaptic and postsynaptic substrates for neuroregulation in prefrontal cortex. Cereb. Cortex 2009, 19:2145-2155.
49. Paul D., Gauthier C.-A., Minor L.-D., Gonzales G.-R. The effects of postmortem delay on mu, delta and kappa opioid receptor subtypes in rat brain and guinea pig cerebellum evaluated by radioligand binding. Life Sci. 1997, 61:1993-1998.
50. Perry E.-K., Perry R.-H. Human brain neurochemistry, some postmortem problems. Life Sci. 1983, 33:1733-1743.
51. Prasad K.-M., Chowdari K.-V., Nimgaonkar V.-L., Talkowski M.-E., Lewis D.-A., Keshavan M.-S. Genetic polymorphisms of the RGS4 and dorsolateral prefrontal cortex morphometry among first episode schizophrenia patients. Mol. Psychiatry 2005, 10:213-219.
52. Ramos-Miguel A., García-Fuster M.-J., Callado L.-F., La Harpe R., Meana J.-J., García-Sevilla J.-A. Phosphorylation of FADD (Fas-associated death domain protein) at derine 194 is increased in the prefrontal cortex of opiate abusers: relation to mitogen activated protein kinase, phosphoprotein enriched in astrocytes of 15kDa, and Akt signalling pathways involved in neuroplasticity. Neuroscience 2009, 161:23-38.
53. Rimler A., Jockers R., Lupowitz Z., Sampson S.-R., Zisapel N. Differential effects of melatonin and its downstream effector PKCalpha on subcellular localization of RGS proteins. J. Pineal Res. 2006, 40:144-152.
54. Rodríguez-Puertas R., Pascual J., Pazos A. Effects of freezing storage time on the density of muscarinic receptors in the human postmortem brain, an autoradiographic study in control and Alzheimer's disease brain tissues. Brain Res. 1996, 728:65-71.
55. Ross E.-M., Wilkie T.-M. GTPase-activating proteins for heterotrimeric G proteins, regulators of G protein signaling (RGS) and RGS-like proteins. Annu. Rev. Biochem. 2000, 69:795-827.
56. Saugstad J.-A., Marino M.-J., Folk J.-A., Hepler J.-R., Conn P.-J. RGS4 inhibits signaling by group I metabotropic glutamate receptors. J. Neurosci. 1998, 18:905-913.
57. Schiff M.-L., Siderovski D.-P., Jordan J.-D., Brothers G., Snow B., De Vries L., Ortiz D.-F., Diverse-Pierluissi M. Tyrosine-kinase-dependent recruitment of RGS12 to the N-type calcium channel. Nature 2000, 408:723-727.
58. Schwendt M., Gold S.-J., McGinty J.-F. Acute amphetamine down-regulates RGS4 mRNA and protein expression in rat forebrain, distinct roles of D1 and D2 dopamine receptors. J. Neurochem. 2006, 96:1606-1615.
59. Shi J., Damjanoska K.-J., Zemaitaitis B.-W., Garcia F., Carrasco G., Sullivan N.-R., She Y., Young K.-H., Battaglia G., Van de Kar L.-D., Howland D.-S., Muma N.-A. Alterations in 5-HT (2A) receptor signaling in male and female transgenic rats over-expressing either Gq or RGS-insensitive Gq protein. Neuropharmacology 2006, 51:524-535.
60. Sierra D.-A., Gilbert D.-J., Householder D., Grishin N.-V., Yu K., Ukidwe P., Barker S.-A., He W., Wensel T.-G., Otero G., Brown G., Copeland N.-G., Jenkins N.-A., Wilkie T.-M. Evolution of the regulators of G-protein signaling multigene family in mouse and human. Genomics 2002, 79:177-185.
61. Sinnarajah S., Dessauer C.-W., Srikumar D., Chen J., Yuen J., Yilma S., Dennis J.-C., Morrison E.-E., Vodyanoy V., Kehrl J.-H. RGS2 regulates signal transduction in olfactory neurons by attenuating activation of adenylyl cyclase III. Nature 2001, 409:1051-1055.
62. Srinivasa S.-P., Bernstein L.-S., Blumer K.-J., Linder M.-E. Plasma membrane localization is required for RGS4 function in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:5584-5589.
63. Talkowski M.-E., Seltman H., Bassett A.-S., Brzustowicz L.-M., Chen X., Chowdari K.-V., Collier D.-A., Cordeiro Q., Corvin A.-P., Deshpande S.-N., Egan M.-F., Gill M., Kendler K.-S., Kirov G., Heston L.-L., Levitt P., Lewis D.-A., Li T., Mirnics K., Morris D.-W., Norton N., O'Donovan M.-C., Owen M.-J., Richard C., Semwal P., Sobell J.-L., St Clair D., Straub R.-E., Thelma B.-K., Vallada H., Weinberger D.-R., Williams N.-M., Wood J., Zhang F., Devlin B., Nimgaonkar V.-L. Evaluation of a susceptibility gene for schizophrenia, genotype based meta-analysis of RGS4 polymorphisms from thirteen independent samples. Biol. Psychiatry 2006, 60:152-162.
64. Tekumalla P.-K., Calon F., Rahman Z., Birdi S., Rajput A.-H., Hornykiewicz O., Di Paolo T., Bedard P.-J., Nestler E.-J. Elevated levels of DeltaFosB and RGS9 in striatum in Parkinson's disease. Biol. Psychiatry 2001, 50:813-816.
65. Tu Y., Woodson J., Ross E.-M. Binding of regulator of G protein signaling (RGS) proteins to phospholipid bilayers-contribution of location and/or orientation to GTPase-activating protein activity. J. Biol. Chem. 2001, 276:20160-20166.
66. Waugh J.-L., Lou A.-C., Eisch A.-J., Monteggia L.-M., Muly E.-C., Gold S.-J. Regional, cellular, and subcellular localization of RGS10 in rodent brain. J. Comp. Neurol. 2005, 481:299-313.
67. Whitehouse P.-J., Lynch D., Kuhar M.-J. Effects of postmortem delay and temperature on neurotransmitter receptor binding in a rat model of the human autopsy process. J. Neurochem. 1984, 43:553-559.
68. Williams N.-M., Preece A., Spurlock G., Norton N., Williams H.-J., McCreadie R.-G., Buckland P., Sharkey V., Chowdari K.-V., Zammit S., Nimgaonkar V., Kirov G., Owen M.-J., O'Donovan M.-C. Support for RGS4 as a susceptibility gene for schizophrenia. Biol. Psychiatry 2004, 55:192-195.
69. Yan Y., Chi P.-P., Bourne H.-R. RGS4 inhibits Gq-mediated activation of mitogen-activated protein kinase and phosphoinositide synthesis. J. Biol. Chem. 1997, 272:11924-11927.
70. Zhong H., Wade S.-M., Woolf P.-J., Linderman J.-J., Traynor J.-R., Neubig R.-R. A spatial focusing model for G protein signals. Regulator of G protein signaling (RGS) protein-mediated kinetic scaffolding. J. Biol. Chem. 2003, 278:7278-7284.